Ligand Presents Full Data from Successful Phase II Trial of Captisol-Enabled®, Propylene Glycol-Free Melphalan at the BMT Tandem Meetings February 2, 2012
Ligand Announces Positive Preclinical Data on Small-Molecule GCSF Receptor Agonist at the 53rd Annual Meeting of the American Society of Hematology December 12, 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn® October 10, 2011